Novel antibodies

Details for Australian Patent Application No. 2008281801 (hide)

Owner Glaxo Group Limited

Inventors Ellis, Jonathan Henry; Hamblin, Paul Andrew

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008281801

PCT Pub. Number WO2009/016164

Priority 60/953,210 01.08.07 US

Filing date 28 July 2008

Wipo publication date 5 February 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/016164 Priority application(s): WO2009/016164

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008281803-Maize having improved digestibility

2008281800-Low energy consumption climate control system and method for the realization of high heat-sound insulation build- ing